Medication info
Crevatin 20 mg (Rosuvastatin Calcium)

Crevatin 20 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets (15 tablets/PTP (AluAlu) x 2)
Approval status
Active

MFDS item code 201602996 · Approved 2016.05.27 · Insurance code 649404870

Summary

Main use
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no treatment experience in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: The recommended initial dose is 5 milligrams in Asian patients because systemic exposure to this medicine is increased. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose is 5 milligrams in patients predisposed to myopathy. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • atherosclerosis
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
View approved original text

This medication is primarily used as an adjunct when diet and exercise alone do not control primary hypercholesterolemia and mixed dyslipidemia. It is also effective as an adjunct to diet or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It is also used as an adjunct in children with heterozygous familial hypercholesterolemia who meet the established criteria. It is helpful as an adjunct to dietary measures in patients with primary dysbetalipoproteinemia and contributes to reducing cardiovascular disease risk. Notably, it is effective in reducing the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged individuals with elevated high-sensitivity C-reactive protein levels. This medication helps improve cholesterol levels and maintain cardiovascular health.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no treatment experience in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Ethnicity: The recommended initial dose is 5 milligrams in Asian patients because systemic exposure to this medicine is increased. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose is 5 milligrams in patients predisposed to myopathy. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this medication, have severe liver dysfunction, have muscle diseases, or have severe kidney disorders should not take it. Women who are pregnant or breastfeeding, as well as women of childbearing age who do not use adequate contraception, must consult a physician before taking this medication, as it may pose risks to the fetus. Additionally, patients with a history of muscle-related disorders or at high risk of muscle damage should avoid high doses of this medication and should closely monitor their muscle condition before and after taking it. This medication contains lactose, making it unsuitable for patients with lactose intolerance or specific genetic metabolic disorders. Patients with liver health issues or those who consume alcohol heavily should have liver function tests before taking this medication and should regularly monitor liver health during treatment. If symptoms such as muscle pain, weakness, or cramps occur, they should promptly inform their physician, and discontinuation of the medication may be required. This medication may interact with various other drugs, so if patients are taking other medications, they must inform their doctor or pharmacist. Caution is especially needed when combined with specific antibiotics, antifungals, immunosuppressants, and fibrates. Pregnant or breastfeeding women, or those planning to become pregnant, should not take this medication and must use adequate contraception. In cases of overdose, there is no specific antidote, so treatment should be based on symptoms, along with liver function and muscle enzyme tests. Caution is required when driving or operating machinery due to potential dizziness or similar symptoms. In rare instances, severe skin reactions, liver damage, or muscle disorders may develop in some patients; if unusual symptoms occur, immediate consultation with healthcare professionals is necessary.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increase in ALT, chest pain, increase in CK, increase in AST, arthralgic pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increase in serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air and moisture. It is recommended to maintain the storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets (15 tablets/PTP (AluAlu) x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.